TriMas Corp (NASDAQ:TRS) Receives Average Recommendation of “Hold” from Analysts
Shares of TriMas Corp (NASDAQ:TRS) have been assigned an average recommendation of “Hold” from the six analysts that are currently covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $34.50.
Separately, BidaskClub upgraded shares of Zynerba Pharmaceuticals from a “hold” rating to a “buy” rating in a research report on Thursday, June 20th.
NASDAQ TRS traded up $0.59 on Friday, hitting $31.31. 5,785 shares of the company were exchanged, compared to its average volume of 131,344. The firm’s 50 day simple moving average is $29.82. The company has a market cap of $1.39 billion, a P/E ratio of 17.87, a P/E/G ratio of 3.19 and a beta of 1.50. The company has a current ratio of 2.86, a quick ratio of 1.61 and a debt-to-equity ratio of 0.46. TriMas has a 1-year low of $25.18 and a 1-year high of $33.45.
In other TriMas news, Director Nancy Gougarty sold 8,037 shares of the company’s stock in a transaction dated Friday, May 17th. The shares were sold at an average price of $30.33, for a total transaction of $243,762.21. Following the transaction, the director now directly owns 24,403 shares in the company, valued at approximately $740,142.99. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Thomas A. Amato sold 14,991 shares of the company’s stock in a transaction dated Friday, May 17th. The shares were sold at an average price of $30.64, for a total transaction of $459,324.24. Following the transaction, the insider now owns 117,713 shares in the company, valued at $3,606,726.32. The disclosure for this sale can be found here. In the last quarter, insiders have sold 54,383 shares of company stock worth $1,649,389. 1.30% of the stock is owned by corporate insiders.
A number of institutional investors have recently added to or reduced their stakes in the business. BlackRock Inc. raised its position in shares of TriMas by 2.6% in the 4th quarter. BlackRock Inc. now owns 3,217,701 shares of the industrial products company’s stock valued at $87,810,000 after acquiring an additional 81,685 shares during the period. Norges Bank acquired a new stake in shares of TriMas in the 4th quarter valued at approximately $29,427,000. Mawer Investment Management Ltd. raised its position in shares of TriMas by 35.3% in the 1st quarter. Mawer Investment Management Ltd. now owns 804,441 shares of the industrial products company’s stock valued at $24,318,000 after acquiring an additional 209,915 shares during the period. Geode Capital Management LLC raised its position in shares of TriMas by 8.8% in the 4th quarter. Geode Capital Management LLC now owns 524,716 shares of the industrial products company’s stock valued at $14,319,000 after acquiring an additional 42,250 shares during the period. Finally, Comerica Bank raised its position in shares of TriMas by 4.3% in the 1st quarter. Comerica Bank now owns 449,242 shares of the industrial products company’s stock valued at $14,398,000 after acquiring an additional 18,323 shares during the period. Institutional investors own 97.71% of the company’s stock.
TriMas Company Profile
TriMas Corporation manufactures and sells products for consumer products, aerospace, industrial, petrochemical, refinery, and oil and gas end markets worldwide. It operates in three segments: Packaging, Aerospace, and Specialty Products. The Packaging segment designs, manufactures, and sells specialty closure products, including steel and plastic drum closures, plastic pail dispensers and plugs, and plastic enclosures; specialty dispensing products, such as foamers, lotion pumps, fine mist sprayers, airless dispensers, and other packaging solutions for the cosmetic, personal care, and household product markets; and specialty plastic closures for bottles and jars in the food and beverage markets under the Rieke name.
Featured Story: Special Dividends
Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.